7Baggers
 BioVie Stockholders Approve Key Proposals at Annual Meeting  TipRanks Wed, 12 Nov 2025 22:40:56 GMT
 BIOVIE INC. SEC 10-Q Report  TradingView Mon, 10 Nov 2025 22:03:00 GMT
 BioVie Inc.’s NE3107: A Promising Study for Long COVID Relief  TipRanks Mon, 27 Oct 2025 07:00:00 GMT
 published on: 2025-10-25 18:06:37  newser.com Sat, 25 Oct 2025 23:06:37 GMT

BioVie Inc
(NASDAQ:BIVI) 

BIVI stock logo

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly...

Founded: 2013
Full Time Employees: 2
CEO: Terren S. Peizer  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends